These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1665122

  • 1. In vitro activity of a new quinolone, rufloxacin, against nosocomial isolates.
    Mattina R, Cocuzza CE, Cesana M, Bonfiglio G.
    Chemotherapy; 1991; 37(4):260-9. PubMed ID: 1665122
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The in-vitro activity of two new quinolones: rufloxacin and MF 961.
    Wise R, Andrews JM, Matthews R, Wolstenholme M.
    J Antimicrob Chemother; 1992 Jun; 29(6):649-60. PubMed ID: 1324239
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
    Harnett SJ, Fraise AP, Andrews JM, Jevons G, Brenwald NP, Wise R.
    J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the mechanism of action and resistance of two new fluoroquinolones, rufloxacin and MF961 with those of ofloxacin and fleroxacin in gram-negative and gram-positive bacteria.
    Piddock LJ, Panchal S, Norte V.
    J Antimicrob Chemother; 1993 Jun; 31(6):855-63. PubMed ID: 8395493
    [Abstract] [Full Text] [Related]

  • 7. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G, Pinsi G, Pirali F, Colombrita D, Foresti I, Peroni L, Turano A.
    Drugs Exp Clin Res; 1989 Jun; 15(1):11-5. PubMed ID: 2743869
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W.
    Chemotherapy; 1998 Jun; 44(2):77-84. PubMed ID: 9551236
    [Abstract] [Full Text] [Related]

  • 9. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
    Imamori K, Asaoka T, Matsumoto M, Maebashi K, Matsuda H, Tahara Y.
    Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
    Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N.
    Drugs Exp Clin Res; 1992 Dec; 18(8):311-7. PubMed ID: 1338041
    [Abstract] [Full Text] [Related]

  • 13. Bactericidal activity, morphological alterations, and synergistic interactions of rufloxacin, a new fluoroquinolone, alone and in combination with its N-desmethylate D derivative (MF 922).
    Marchese A, Debbia EA, Pesce A, Schito GC.
    Chemotherapy; 1996 Dec; 42(2):90-9. PubMed ID: 8697894
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM, Lee GC, Ellis ME.
    Chemotherapy; 1991 Dec; 37(3):166-74. PubMed ID: 1889304
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H, Hayakawa I, Akimoto T.
    Yakushigaku Zasshi; 2003 Dec; 38(2):161-79. PubMed ID: 15143768
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility of Salmonella typhi and Brucella melitensis to the new fluoroquinolone rufloxacin (MF 934).
    Qadri SM, Ayub A, Ueno Y, Saldin H.
    Chemotherapy; 1993 Dec; 39(5):311-4. PubMed ID: 8396527
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
    Louie A, Baltch AL, Ritz WJ, Smith RP.
    Chemotherapy; 1991 Dec; 37(4):275-82. PubMed ID: 1665123
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.